Arthur Kuan

Director, Chief Executive Officer · 3 filings · Latest: Apr 15, 2026

CG Oncology, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
CGON	Arthur Kuan	Director, Chief Executive Officer	Mar 12, 2026	Option Exercise	$1.72	64,612	$111.1K	200,763	Mar 13 8:09 PM
CGON	Arthur Kuan	Director, Chief Executive Officer	Mar 4, 2026	Option Exercise	$1.72	102,871	$176.9K	139,022	Mar 6 10:52 PM